factual
Rise of non-inferiority trials signals picked low-hanging fruit
Many trials in top journals today are non-inferiority trials—comparing a new therapy to an accepted one merely to show it is not worse, justified by advantages like better tolerability or less invasiveness rather than greater efficacy or lower cost—which signals that medicine has already captured its large breakthroughs and now mostly produces small incremental advances.
factualpending
Speaker
Adam CifuEvidence Quote
“many of the trials these days are not inferiority trials”
Created: 6/13/2026, 12:18:13 AM
Your notes
Loading notes...